A novel method for the fabrication of highly uniform oxide dispersion-strengthened (ODS) materials made by chemical processing is presented. The powders are fabricated by a two-step route starting with a chemical synthesis at room temperature, producing nanocrystalline yttrium doped tungsten trioxide hydrate precursor powders. Thermogravimetric analysis with evolved gas analysis revealed the presence of ammonium nitrate in the precursors. The second step is the reduction of the precursor in a hydrogen atmosphere at 600 and 800 °C. The reduced powders, containing W-1.2%Y₂O₃, showed two types of tungsten particles, cube-shaped with a size less than 250 nm and finer particles (<50 nm) of both spherical and cubic shape. The powder was consolidated by spark plasma sintering at 1100 °C, producing a bulk material with a relative density of 88%. Characterization of the sintered materials by high resolution scanning electron microscopy revealed a uniform microstructure with tungsten grains of less than 300 nm and nanosized oxide particles uniformly dispersed at the tungsten grain boundaries, as well as inside the tungsten grains. Experimental determination of the elastic properties was conducted by nanoindentation tests and fracture toughness was studied by radial indentation cracking.

Multifunctional nanocarriers for controlled drug delivery, imaging of disease development and follow-up of treatment efficacy are promising novel tools for disease diagnosis and treatment. In the current investigation, we present a multifunctional theranostic nanocarrier system for anticancer drug delivery and molecular imaging. Superparamagnetic iron oxide nanoparticles (SPIONs) as an MRI contrast agent and busulphan as a model for lipophilic antineoplastic drugs were encapsulated into poly (ethylene glycol)-co-poly (caprolactone) (PEG-PCL) micelles via the emulsion-evaporation method, and PEG-PCL was labelled with VivoTag 680XL fluorochrome for in vivo fluorescence imaging. Busulphan entrapment efficiency was 83% while the drug release showed a sustained pattern over 10 h. SPION loaded-PEG-PCL micelles showed contrast enhancement in T 2 *-weighted MRI with high r 2* relaxivity. In vitro cellular uptake of PEG-PCL micelles labeled with fluorescein in J774A cells was found to be time-dependent. The maximum uptake was observed after 24 h of incubation. The biodistribution of PEG-PCL micelles functionalized with VivoTag 680XL was investigated in Balb/c mice over 48 h using in vivo fluorescence imaging. The results of real-time live imaging were then confirmed by ex vivo organ imaging and histological examination. Generally, PEG-PCL micelles were highly distributed into the lungs during the first 4 h post intravenous administration, then redistributed and accumulated in liver and spleen until 48 h post administration. No pathological impairment was found in the major organs studied. Thus, with loaded contrast agent and conjugated fluorochrome, PEG-PCL micelles as biodegradable and biocompatible nanocarriers are efficient multimodal imaging agents, offering high drug loading capacity, and sustained drug release. These might offer high treatment efficacy and real-time tracking of the drug delivery system in vivo, which is crucial for designing of an efficient drug delivery system.